A nanocarrier-packaged carnosic acid alleviates microglia and astrocytes-associated neuronal degeneration and decreases Aβ deposition by suppressing the CEBPβ-NF-κB signaling and further improves cognition in AD [122]. The gene discussed is CEBPB; the disease is Alzheimer disease.